Amyloidosis Research Consortium
@amyloidosis.bsky.social
ARC is accelerating the development of and access to new and innovative treatments for systemic #amyloidosis
Thank you to our supporters who have made this annual meeting possible!
October 22, 2025 at 2:06 PM
Thank you to our supporters who have made this annual meeting possible!
This activity is supported by an independent educational grant from AstraZeneca and Ionis Pharmaceuticals.
July 22, 2025 at 5:54 PM
This activity is supported by an independent educational grant from AstraZeneca and Ionis Pharmaceuticals.
And thank you to the centers mentoring these wonderful #amyloidosis fellows!
Boston Medical Center
Boston University School of Medicine
Columbia Medical Center
Mass General Brigham
Northwestern University
Oregon Health & Science University
University of Chicago
Endeavor Health
UTSW Medical Center
Boston Medical Center
Boston University School of Medicine
Columbia Medical Center
Mass General Brigham
Northwestern University
Oregon Health & Science University
University of Chicago
Endeavor Health
UTSW Medical Center
July 22, 2025 at 5:54 PM
And thank you to the centers mentoring these wonderful #amyloidosis fellows!
Boston Medical Center
Boston University School of Medicine
Columbia Medical Center
Mass General Brigham
Northwestern University
Oregon Health & Science University
University of Chicago
Endeavor Health
UTSW Medical Center
Boston Medical Center
Boston University School of Medicine
Columbia Medical Center
Mass General Brigham
Northwestern University
Oregon Health & Science University
University of Chicago
Endeavor Health
UTSW Medical Center
ARC remains steadfast in our commitment to accelerating the development of new therapies and improving the lives of people living with #AL #amyloidosis. We will continue to keep you informed about developments in amyloidosis as they become available.
May 23, 2025 at 9:27 PM
ARC remains steadfast in our commitment to accelerating the development of new therapies and improving the lives of people living with #AL #amyloidosis. We will continue to keep you informed about developments in amyloidosis as they become available.